Genmab A/S (GNMSF)
301.28
-0.69
(-0.23%)
USD |
OTCM |
May 17, 16:00
Genmab Price: 301.28 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 301.28 | 301.28 | 290.42 | 301.28 | 297.00 |
May 16, 2024 | 301.97 | 301.97 | 291.08 | 301.97 | 856.00 |
May 15, 2024 | 302.46 | 302.46 | 287.90 | 291.54 | 54.00 |
May 14, 2024 | 287.80 | 298.60 | 287.80 | 287.80 | 244.00 |
May 13, 2024 | 281.13 | 291.72 | 281.13 | 281.13 | 209.00 |
May 10, 2024 | 292.36 | 300.35 | 288.49 | 290.48 | 328.00 |
May 09, 2024 | 295.25 | 295.25 | 284.45 | 284.45 | 214.00 |
May 08, 2024 | 293.74 | 293.89 | 274.16 | 278.34 | 810.00 |
May 07, 2024 | 283.92 | 294.63 | 283.92 | 283.92 | 577.00 |
May 06, 2024 | 285.91 | 296.59 | 285.91 | 296.59 | 255.00 |
May 03, 2024 | 295.00 | 301.37 | 282.69 | 289.74 | 375.00 |
May 02, 2024 | 287.03 | 287.03 | 272.95 | 276.47 | 160.00 |
May 01, 2024 | 272.81 | 284.99 | 272.81 | 272.81 | 161.00 |
Apr 30, 2024 | 274.22 | 284.63 | 274.22 | 274.22 | 120.00 |
Apr 29, 2024 | 285.43 | 285.43 | 272.05 | 272.05 | 497.00 |
Apr 26, 2024 | 274.35 | 288.15 | 269.75 | 274.35 | 626.00 |
Apr 25, 2024 | 269.87 | 283.58 | 265.30 | 269.87 | 314.00 |
Apr 24, 2024 | 279.24 | 290.40 | 275.55 | 279.60 | 1217.00 |
Apr 23, 2024 | 280.41 | 294.54 | 279.36 | 290.34 | 343.00 |
Apr 22, 2024 | 279.76 | 290.53 | 279.76 | 289.67 | 5321.00 |
Apr 19, 2024 | 287.06 | 288.30 | 283.30 | 284.55 | 241.00 |
Apr 18, 2024 | 281.08 | 290.38 | 279.82 | 290.38 | 217.00 |
Apr 17, 2024 | 282.20 | 292.85 | 278.65 | 281.02 | 212.00 |
Apr 16, 2024 | 295.94 | 295.94 | 285.11 | 285.11 | 417.00 |
Apr 15, 2024 | 295.59 | 295.59 | 278.46 | 282.00 | 206.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
159.80
Minimum
Mar 16 2020
499.37
Maximum
Sep 02 2021
334.77
Average
352.92
Median
Apr 15 2021
Price Benchmarks
Ascendis Pharma A/S | 120.97 |
Galecto Inc | 0.6179 |
Evaxion Biotech AS | 3.72 |
IO Biotech Inc | 1.39 |
Price Related Metrics
PE Ratio | 24.97 |
PS Ratio | 7.675 |
PEG Ratio | 2.406 |
Price to Book Value | 4.140 |
Price to Free Cash Flow | 25.38 |
Earnings Yield | 4.01% |
Market Cap | 19.46B |
PEGY Ratio | 2.406 |
Operating PE Ratio | 23.98 |
Normalized PE Ratio | 26.90 |